Connor L Martin5265 Toscana Way APT 2310, San Diego, CA 92122

Connor Martin Phones & Addresses

5265 Toscana Way APT 2310, San Diego, CA 92122 (618) 741-8955

2552 Westmoreland Dr, Granite City, IL 62040

Cambridge, MA

Irvine, CA

O Fallon, IL

Grant, FL

950 Massachusetts Ave APT 61, Cambridge, MA 02139

Show more

Work

Company: Hope of the valley Aug 2013 Position: Retail associate

Education

School / High School: Unknown- Altadena, CA 2008 Specialities: High School Diploma in General Education

Skills

Team work • communication skills • good work and completing task on time • stayed foced on the current task.

Mentions for Connor L Martin

Resumes & CV records

Resumes

Connor Martin Photo 43

Senior Scientist

Location:
San Diego, CA
Industry:
Research
Work:
The Janssen Pharmaceutical Companies of Johnson & Johnson
Senior Scientist
The Janssen Pharmaceutical Companies of Johnson & Johnson Sep 1, 2012 - Sep 2015
Scientist
Harvard University Feb 2011 - Aug 2012
Nih Postdoctoral Fellow
Advanced Asymmetrics 2005 - 2006
Chemist
Sigma-Aldrich 2002 - 2003
Co-Op
Education:
Uc Irvine 2006 - 2010
Doctorates, Doctor of Philosophy, Organic Chemistry
Washington University In St. Louis 2003 - 2005
Bachelors, Bachelor of Arts, Chemistry
Florida Institute of Technology 2000 - 2002
Skills:
Medicinal Chemistry, Organic Synthesis, Organic Chemistry, Catalysis
Connor Martin Photo 44

Senior Marketing Analytics Analyst

Location:
522 Quarry View Way, Spring Valley, CA 91977
Industry:
Restaurants
Work:
Hologic, Inc.
Senior Marketing Analytics Analyst
Cerca Trova Restaurant Concepts
Senior Analyst, Fp and A
Realty Income Corporation Dec 2015 - Jan 2018
Corporate Financial Analyst
Utc Aerospace Systems Jan 2014 - Dec 2015
Business and Operations Analyst, Aftermarket
Jack In the Box Jan 2013 - Dec 2013
Real Estate and Assets Internship
Education:
San Diego State University 2013 - 2017
Masters, Applied Economics
San Diego State University 2009 - 2013
Skills:
Customer Service, Microsoft Excel, Microsoft Office, Economic Forecasting, Retail, Financial Analysis, Powerpoint, Microsoft Word, Data Analytics, New Business Development, Commercial Real Estate, Asset Management, Data Modeling, Food, Pricing Strategy, Property Management, Corporate Real Estate, Investments, Financial Modeling, Real Estate, Rental Real Estate, Real Estate Investment Trust, Franchise Business Development, Reit Finance, Nnn Real Estate, Data Management, Underwriting, Retail Real Estate, Financial Reporting, Property Taxes, Real Estate Finance, Sql, Query Writing, Data Visualization, Business Analysis, Product Mix, Marketing Analytics, P&L Analysis, Operations Analysis, Leadership, Lto Analysis, Pricing Analysis, Marketing Strategy, Market Research, Consumer Goods, Retail Sales Analysis, Consulting, Restaurant Consultant, Menu Costing, Menu Engineering
Languages:
English
Connor Martin Photo 45

Cert Presenter And Personal Trainer

Location:
San Diego, CA
Industry:
Health, Wellness And Fitness
Work:
Crossfit, Inc.
Cert Presenter and Personal Trainer
Connor Martin Photo 46

Licensed Realtor

Work:

Licensed Realtor
Connor Martin Photo 47

Connor Martin

Connor Martin Photo 48

Connor Martin

Connor Martin Photo 49

Connor Martin

Connor Martin Photo 50

Connor Martin

Publications & IP owners

Us Patents

Phenyl And Pyridinyl Substituted Imidazoles As Modulators Of Rorgt

US Patent:
2022028, Sep 8, 2022
Filed:
May 5, 2022
Appl. No.:
17/737113
Inventors:
- Beers, BE
Connor L. Martin - San Diego CA, US
Elizabeth G. Fennema - La Mesa CA, US
David A. Kummer - San Diego CA, US
Rachel T. Nishimura - San Diego CA, US
Virginia M. Tanis - Vista CA, US
Craig R. Woods - San Diego CA, US
Anne M. Fourie - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
C07D 233/90
C07D 401/04
Abstract:
The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, R, Q, and Qare defined in the specification.The invention also comprises a method of treating or ameliorating a ROR-γ-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

Imidazopyridazines As Modulators Of Il-17

US Patent:
2023008, Mar 16, 2023
Filed:
Jan 14, 2022
Appl. No.:
17/576535
Inventors:
- Beerse, BE
Craig WOODS - San Diego CA, US
Timothy B. RHORER - San Diego CA, US
Connor MARTIN - San Diego CA, US
Steven P. MEDUNA - San Diego CA, US
Stefan McCARVER - San Diego CA, US
Alexander VALDES - San Diego CA, US
Steven LOSKOT - San Diego CA, US
Douglas BEHENNA - San Juan Capistrano CA, US
Xiaohua XUE - San Diego CA, US
International Classification:
C07D 487/04
Abstract:
The present application discloses compounds having the following formula:or pharmaceutically acceptable salts thereof, wherein R, R, R, Rand Rare defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.

6-Aminopyridin-3-Yl Thiazoles As Modulators Of Roryt

US Patent:
2021022, Jul 22, 2021
Filed:
Feb 23, 2021
Appl. No.:
17/182363
Inventors:
- Beerse, BE
Kelly McClure - Ramona CA, US
Virginia M. Tanis - Vista CA, US
Elizabeth G. Fennema - La Mesa CA, US
Alec D. Lebsack - Ladera Ranch CA, US
Connor L. Martin - San Diego CA, US
Hariharan Venkatesan - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Craig R. Woods - San Diego CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
C07D 417/14
C07D 417/04
C07B 59/00
C07D 487/08
C07D 491/08
C07D 491/107
C07D 498/08
Abstract:
The present invention comprises compounds of Formula I.wherein:A, A, A, A, A, R, and Rare defined in the specification.The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein the syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

Magnetic Coupling Shade System For Boats

US Patent:
2020010, Apr 9, 2020
Filed:
Oct 3, 2019
Appl. No.:
16/592668
Inventors:
Connor Martin - Newport Beach CA, US
Garret Martin - Newport Beach CA, US
International Classification:
B63B 17/02
Abstract:
Systems and methods are provided for a magnetic coupling shade system for boats. The magnetic coupling shade system comprises a sheet of material that includes magnetic portions coupled with magnets disposed in locations of a boat. The locations of the boat include any of the hull, deck, superstructure, hardtop, or any other suitable surface of the boat. Magnets located on the hull are located within the interior of the hull. The sheet extends from the top to either or both of the port and starboard sides. The sheet can comprise a variety of materials, and may include a window portion for viewing through the sheet. In some embodiments, the window portion comprises an entirety of the sheet with the magnetic portions attached to opposite edges of the window portion. The sheet is configured to be detached from the magnets and either suspended overhead or rolled upward when not in use.

Phenyl Substituted Pyrazoles As Modulators Of Rorgt

US Patent:
2019038, Dec 19, 2019
Filed:
Jun 17, 2019
Appl. No.:
16/442837
Inventors:
- Beerse, BE
Connor L. Martin - San Diego CA, US
Elizabeth G. Fennema - La Mesa CA, US
David A. Kummer - San Diego CA, US
Rachel T. Nishimura - San Diego CA, US
Craig R. Woods - San Diego CA, US
Ronald L. Wolin - San Diego CA, US
William M. Jones - Jenkintown PA, US
Anne M. Fourie - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
C07D 231/14
C07D 401/12
C07D 403/10
C07D 405/12
Abstract:
The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, R, and Q are defined in the specification.The invention also comprises a method of treating or ameliorating a ROR-γ-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

Pyridinyl Pyrazoles As Modulators Of Roryt

US Patent:
2019038, Dec 19, 2019
Filed:
Jun 17, 2019
Appl. No.:
16/442976
Inventors:
- Beerse, BE
Connor L. Martin - San Diego CA, US
Elizabeth G. Fennema - La Mesa CA, US
Ronald L. Wolin - San Diego CA, US
Anne M. Fourie - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
C07D 231/14
A61P 37/06
A61P 25/24
A61P 17/06
C07D 401/04
Abstract:
The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, and Q are defined in the specification.The invention also comprises a method of treating or ameliorating a ROR-γ-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

Phenyl And Pyridinyl Substituted Imidazoles As Modulators Of Roryt

US Patent:
2019038, Dec 19, 2019
Filed:
Jun 17, 2019
Appl. No.:
16/442864
Inventors:
- Beerse, BE
Connor L. Martin - San Diego CA, US
Elizabeth G. Fennema - La Mesa CA, US
David A. Kummer - San Diego CA, US
Rachel T. Nishimura - San Diego CA, US
Virginia M. Tanis - Vista CA, US
Craig R. Woods - San Diego CA, US
Anne M. Fourie - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
C07D 233/90
C07D 401/04
Abstract:
The present invention comprises compounds of Formula I.wherein:R, R, R, R, R, R, R, Q, and Qare defined in the specification.The invention also comprises a method of treating or ameliorating a ROR-γ-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

6-Aminopyridin-3-Yl Pyrazoles As Modulators Of Rorgt

US Patent:
2019038, Dec 19, 2019
Filed:
Jun 17, 2019
Appl. No.:
16/442897
Inventors:
- Beerse, BE
Connor L. Martin - San Diego CA, US
Elizabeth G. Fennema - La Mesa CA, US
David A. Kummer - San Diego CA, US
Rachel T. Nishimura - San Diego CA, US
Anne M. Fourie - San Diego CA, US
Xiaohua Xue - San Diego CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
C07D 401/14
C07D 401/04
A61P 37/02
Abstract:
The present invention comprises compounds of Formula I.wherein:R, Q, R, R, R, R, A, and Aare defined in the specification.The invention also comprises a method of treating or ameliorating a ROR-γ-t mediated syndrome, disorder or disease, including wherein the syndrome, disorder or disease is selected from the group consisting of rheumatoid arthritis, psoriatic arthritis, and psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.